FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080948832> ?p ?o ?g. }

• W3080948832 endingPage "1530" @default.
• W3080948832 startingPage "1522" @default.
• W3080948832 abstract "Coagulopathy causes morbidity and mortality in patients with coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Yet, the mechanisms are unclear and biomarkers are limited. Early in the pandemic, we observed markedly elevated factor V activity in a patient with COVID-19, which led us to measure factor V, VIII, and X activity in a cohort of 102 consecutive inpatients with COVID-19. Contemporaneous SARS-CoV-2-negative controls (n = 17) and historical pre-pandemic controls (n = 260-478) were also analyzed. This cohort represents severe COVID-19 with high rates of ventilator use (92%), line clots (47%), deep vein thrombosis or pulmonary embolism (DVT/PE) (23%), and mortality (22%). Factor V activity was significantly elevated in COVID-19 (median 150 IU/dL, range 34-248 IU/dL) compared to contemporaneous controls (median 105 IU/dL, range 22-161 IU/dL) (P < .001)-the strongest association with COVID-19 of any parameter studied, including factor VIII, fibrinogen, and D-dimer. Patients with COVID-19 and factor V activity >150 IU/dL exhibited significantly higher rates of DVT/PE (16/49, 33%) compared to those with factor V activity ≤150 IU/dL (7/53, 13%) (P = .03). Within this severe COVID-19 cohort, factor V activity associated with SARS-CoV-2 load in a sex-dependent manner. Subsequent decreases in factor V were linked to progression toward DIC and mortality. Together, these data reveal marked perturbations of factor V activity in severe COVID-19, provide links to SARS-CoV-2 disease biology and clinical outcomes, and nominate a candidate biomarker to investigate for guiding anticoagulation therapy in COVID-19." @default.
• W3080948832 created "2020-09-01" @default.
• W3080948832 creator A5001475253 @default.
• W3080948832 creator A5002543285 @default.
• W3080948832 creator A5016049128 @default.
• W3080948832 creator A5025103900 @default.
• W3080948832 creator A5041510232 @default.
• W3080948832 creator A5055811107 @default.
• W3080948832 creator A5059927074 @default.
• W3080948832 date "2020-09-18" @default.
• W3080948832 modified "2023-09-27" @default.
• W3080948832 title "Marked factor V activity elevation in severe <scp>COVID</scp>‐19 is associated with venous thromboembolism" @default.
• W3080948832 cites W1574141134 @default.
• W3080948832 cites W1988345931 @default.
• W3080948832 cites W2013241037 @default.
• W3080948832 cites W2101371933 @default.
• W3080948832 cites W2295109460 @default.
• W3080948832 cites W2751737337 @default.
• W3080948832 cites W2805891244 @default.
• W3080948832 cites W2911093128 @default.
• W3080948832 cites W2954965037 @default.
• W3080948832 cites W3001118548 @default.
• W3080948832 cites W3008461878 @default.
• W3080948832 cites W3008827533 @default.
• W3080948832 cites W3009885589 @default.
• W3080948832 cites W3010344953 @default.
• W3080948832 cites W3011610993 @default.
• W3080948832 cites W3012232836 @default.
• W3080948832 cites W3012860481 @default.
• W3080948832 cites W3013486442 @default.
• W3080948832 cites W3013710636 @default.
• W3080948832 cites W3014573995 @default.
• W3080948832 cites W3014713654 @default.
• W3080948832 cites W3015863623 @default.
• W3080948832 cites W3016126001 @default.
• W3080948832 cites W3016327048 @default.
• W3080948832 cites W3016965546 @default.
• W3080948832 cites W3017293186 @default.
• W3080948832 cites W3017343267 @default.
• W3080948832 cites W3019046211 @default.
• W3080948832 cites W3020168167 @default.
• W3080948832 cites W3020710323 @default.
• W3080948832 cites W3020735691 @default.
• W3080948832 cites W3023452186 @default.
• W3080948832 cites W3023873927 @default.
• W3080948832 cites W3025200871 @default.
• W3080948832 cites W3027918021 @default.
• W3080948832 cites W3028989873 @default.
• W3080948832 cites W3029676992 @default.
• W3080948832 cites W3037229948 @default.
• W3080948832 cites W3043049174 @default.
• W3080948832 cites W3080948832 @default.
• W3080948832 cites W3165656738 @default.
• W3080948832 cites W335124151 @default.
• W3080948832 cites W4251215049 @default.
• W3080948832 doi "https://doi.org/10.1002/ajh.25979" @default.
• W3080948832 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7461432" @default.
• W3080948832 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32833259" @default.
• W3080948832 hasPublicationYear "2020" @default.
• W3080948832 type Work @default.
• W3080948832 sameAs 3080948832 @default.
• W3080948832 citedByCount "69" @default.
• W3080948832 countsByYear W30809488322020 @default.
• W3080948832 countsByYear W30809488322021 @default.
• W3080948832 countsByYear W30809488322022 @default.
• W3080948832 countsByYear W30809488322023 @default.
• W3080948832 crossrefType "journal-article" @default.
• W3080948832 hasAuthorship W3080948832A5001475253 @default.
• W3080948832 hasAuthorship W3080948832A5002543285 @default.
• W3080948832 hasAuthorship W3080948832A5016049128 @default.
• W3080948832 hasAuthorship W3080948832A5025103900 @default.
• W3080948832 hasAuthorship W3080948832A5041510232 @default.
• W3080948832 hasAuthorship W3080948832A5055811107 @default.
• W3080948832 hasAuthorship W3080948832A5059927074 @default.
• W3080948832 hasBestOaLocation W30809488321 @default.
• W3080948832 hasConcept C126322002 @default.
• W3080948832 hasConcept C2776046644 @default.
• W3080948832 hasConcept C2776265017 @default.
• W3080948832 hasConcept C2778959117 @default.
• W3080948832 hasConcept C2779134260 @default.
• W3080948832 hasConcept C2779519742 @default.
• W3080948832 hasConcept C2779936836 @default.
• W3080948832 hasConcept C2780011451 @default.
• W3080948832 hasConcept C2780868729 @default.
• W3080948832 hasConcept C3008058167 @default.
• W3080948832 hasConcept C50440223 @default.
• W3080948832 hasConcept C524204448 @default.
• W3080948832 hasConcept C71924100 @default.
• W3080948832 hasConcept C72563966 @default.
• W3080948832 hasConcept C90924648 @default.
• W3080948832 hasConceptScore W3080948832C126322002 @default.
• W3080948832 hasConceptScore W3080948832C2776046644 @default.
• W3080948832 hasConceptScore W3080948832C2776265017 @default.
• W3080948832 hasConceptScore W3080948832C2778959117 @default.
• W3080948832 hasConceptScore W3080948832C2779134260 @default.
• W3080948832 hasConceptScore W3080948832C2779519742 @default.
• W3080948832 hasConceptScore W3080948832C2779936836 @default.
• W3080948832 hasConceptScore W3080948832C2780011451 @default.

• next